NEP
Combined inhibition of neutral endopeptidase 24.11 (NEP) and angiotensin       converting enzyme (ACE) is a candidate therapy for hypertension and cardiac       failure.
Combined inhibition of neutral endopeptidase 24.11 ( @SUBJECT$  @PREDICAT$  @OBJECT$  for hypertension and cardiac       failure.